BR0014294A - Quinazolinonas - Google Patents
QuinazolinonasInfo
- Publication number
- BR0014294A BR0014294A BR0014294-8A BR0014294A BR0014294A BR 0014294 A BR0014294 A BR 0014294A BR 0014294 A BR0014294 A BR 0014294A BR 0014294 A BR0014294 A BR 0014294A
- Authority
- BR
- Brazil
- Prior art keywords
- quinazolinones
- ibix
- solvates
- salts
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40795899A | 1999-09-28 | 1999-09-28 | |
| PCT/EP2000/008940 WO2001023365A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0014294A true BR0014294A (pt) | 2002-05-21 |
Family
ID=23614261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0014294-8A BR0014294A (pt) | 1999-09-28 | 2000-09-13 | Quinazolinonas |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1216235A1 (ko) |
| KR (1) | KR20020047186A (ko) |
| AR (1) | AR025797A1 (ko) |
| AU (1) | AU7654800A (ko) |
| BR (1) | BR0014294A (ko) |
| CA (1) | CA2385921A1 (ko) |
| NO (1) | NO20021502L (ko) |
| WO (1) | WO2001023365A1 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| AU2003238157A1 (en) * | 2002-06-18 | 2003-12-31 | Sankyo Company, Limited | Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
| US20040152696A1 (en) * | 2002-08-01 | 2004-08-05 | Euro-Celtique S.A. | 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| AU2003291761A1 (en) * | 2002-11-04 | 2004-06-07 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670416A1 (de) * | 1966-12-30 | 1971-02-11 | Chem Fab Von Heyden Gmbh Muenc | Verfahren zur Herstellung von aminosubstituierten Chinazolinonderivaten |
| JPS6136273A (ja) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | ２−フエニルアルキル−４（３ｈ）−キナゾリノン誘導体 |
| AU679344B2 (en) * | 1994-03-08 | 1997-06-26 | Otsuka Pharmaceutical Factory, Inc. | Phosphonic diester derivative |
| US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
-
2000
- 2000-09-13 AU AU76548/00A patent/AU7654800A/en not_active Abandoned
- 2000-09-13 EP EP00965991A patent/EP1216235A1/en not_active Withdrawn
- 2000-09-13 BR BR0014294-8A patent/BR0014294A/pt not_active Application Discontinuation
- 2000-09-13 KR KR1020027003907A patent/KR20020047186A/ko not_active Application Discontinuation
- 2000-09-13 CA CA002385921A patent/CA2385921A1/en not_active Abandoned
- 2000-09-13 WO PCT/EP2000/008940 patent/WO2001023365A1/en not_active Application Discontinuation
- 2000-09-27 AR ARP000105076A patent/AR025797A1/es unknown
-
2002
- 2002-03-26 NO NO20021502A patent/NO20021502L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7654800A (en) | 2001-04-30 |
| KR20020047186A (ko) | 2002-06-21 |
| AR025797A1 (es) | 2002-12-11 |
| CA2385921A1 (en) | 2001-04-05 |
| WO2001023365A1 (en) | 2001-04-05 |
| NO20021502D0 (no) | 2002-03-26 |
| NO20021502L (no) | 2002-03-26 |
| EP1216235A1 (en) | 2002-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114020A (pt) | 4-amino-quinazolinas | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| BR9815518A (pt) | Agentes antibacterianos de oxazolidinona tendo funcionalidade de tiocarbonila | |
| BR0014078A (pt) | Inibidores de fator xa | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| ATE225341T1 (de) | In 6-position durch thio substituierte paclitaxele | |
| BR9916896A (pt) | Diaril aminas substituìdas com 1-heterociclo | |
| BR9916833A (pt) | Derivados de epotilona e seu uso como agentes antitumor | |
| TR200200795T2 (tr) | 5-HT1B antagonistleri olarak piperazin türevleri | |
| BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
| BR0007595A (pt) | 4-(heterociclisulfonamido)-5-metóxi-6-(2-metoxifenó xi)-2-fenil-ou piridilpirimidinas como antagonistas de receptor de endotelina | |
| ATE234812T1 (de) | Integrin antagonisten | |
| ES2184077T3 (es) | Nuevas fenantridinas sustituidas en la posicion 6. | |
| PT998460E (pt) | Novos derivados de tetrazole | |
| BR0014311A (pt) | Quinazolinonas | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| BR0003474A (pt) | Artigo absorvente compreendendo fibras floculadas | |
| BR9909486A (pt) | Compostos calcilìticos | |
| BR9803704A (pt) | Quinazolina-4-ona como antagonistas do ampa. | |
| BR9915611A (pt) | Benzo [de] isoquinolina-1,3-dionas substituìdas | |
| BR9607335A (pt) | Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1 | |
| BR9910032A (pt) | Tienopirimidinas | |
| BR9916324A (pt) | 4,5-pirazinoxindóis como inibidores de proteìna quinase | |
| BR9915648A (pt) | Benzo [de] isoquinolina-1,3-dionas substituìdas | |
| BR0114021A (pt) | 4-amino-quinazolinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |